Neos Therapeutics (NEOS) Reports Q2 Loss of $1.65/Share

Neos Therapeutics (NASDAQ: NEOS) reported Q2 EPS of ($1.65), versus ($7.76) reported last year. Revenue for the quarter came in at $1.49 million, versus $1.48 million reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Gaming and Leisure Properties (GLPI) Misses Q1 EPS by 6c
• Allison Transmission (ALSN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY24 Revenue Guidance